Comparison Between Epidermal Growth Factor Receptor (EGFR) Gene Expression in Primary Non-small Cell Lung Cancer (NSCLC) and in Fine-Needle Aspirates from Distant Metastatic Sites
- 1 January 2008
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 3 (1) , 18-22
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Selecting Lung Cancer Patients for Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors by Immunohistochemistry and FluorescenceIn situHybridization—Why, When, and How?Clinical Cancer Research, 2006
- Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitorsAnnals of Oncology, 2006
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeNew England Journal of Medicine, 2005
- Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Epidermal Growth Factor Receptor Mutations in Non–Small-Cell Lung Cancer: Implications for Treatment and Tumor BiologyJournal of Clinical Oncology, 2005
- Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinomaCancer, 2003
- Epidermal growth factor receptor expression, signal pathway, and inhibitors in non[ndash ]small cell lung cancerSeminars in Oncology, 2002
- Lung Cancer — Time to Move on from ChemotherapyNew England Journal of Medicine, 2002